| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.951396 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20250828135915 |
|---|
| 006 | m o d f |
|---|
| 007 | cr mn||||||||| |
|---|
| 008 | 250527e202506##onc ob f000 0 eng d |
|---|
| 020 | |a9780660774299 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-394/2025E-PDF |
|---|
| 245 | 00|aGuidance document on submission information for biologic drugs (Division 4, Schedule D). |
|---|
| 246 | 17|aHealth Canada guidance document : |bbiologic drugs |
|---|
| 264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |cJune 2025. |
|---|
| 264 | 4|c©2025 |
|---|
| 300 | |a1 online resource (ii, 35 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Ligne directrice sur les informations à soumettre pour les médicaments biologiques (titre 4, annexe D). |
|---|
| 500 | |aTitle from cover. |
|---|
| 500 | |a"Date: 2025-06." |
|---|
| 500 | |a"Pub.: 250073"--Verso of cover. |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 650 | 0|aBiologicals|xGovernment policy|zCanada. |
|---|
| 650 | 0|aPharmaceutical industry|xGovernment policy|zCanada. |
|---|
| 650 | 0|aBiologicals|xLaw and legislation|zCanada. |
|---|
| 650 | 0|aDrugs|xLaw and legislation|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tLigne directrice sur les informations à soumettre pour les médicaments biologiques (titre 4, annexe D).|w(CaOODSP)9.951397 |
|---|
| 856 | 40|qPDF|s696 KB|uhttps://publications.gc.ca/collections/collection_2025/sc-hc/H164-394-2025-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/submission-information-biologic-drugs-division-4-schedule-d.html |
|---|
| 986 | |a250073 |
|---|